Huawei Zou

889 total citations
36 papers, 710 citations indexed

About

Huawei Zou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huawei Zou has authored 36 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Huawei Zou's work include MicroRNA in disease regulation (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Epigenetics and DNA Methylation (4 papers). Huawei Zou is often cited by papers focused on MicroRNA in disease regulation (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Epigenetics and DNA Methylation (4 papers). Huawei Zou collaborates with scholars based in China, United States and Hong Kong. Huawei Zou's co-authors include Cheng‐Bo Han, Jie‐Tao Ma, Kai Li, Shunchao Yan, Xin Jiao, Heying Zhang, Cheng Sun, Fan Li, Yuexian Li and Kexin Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Huawei Zou

36 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huawei Zou China 16 403 322 244 163 70 36 710
Liang Jin China 15 344 0.9× 413 1.3× 342 1.4× 166 1.0× 140 2.0× 32 822
Tomohiro Sakuma Japan 17 356 0.9× 253 0.8× 282 1.2× 213 1.3× 65 0.9× 23 796
Maïa Chanrion France 7 513 1.3× 196 0.6× 231 0.9× 86 0.5× 69 1.0× 9 751
Jamie R. Kutasovic Australia 15 304 0.8× 319 1.0× 348 1.4× 181 1.1× 139 2.0× 19 762
Linquan Wu China 15 460 1.1× 311 1.0× 167 0.7× 144 0.9× 58 0.8× 34 714
Jinjia Chang China 15 430 1.1× 284 0.9× 279 1.1× 161 1.0× 71 1.0× 31 740
Jeanie Wu Singapore 13 552 1.4× 258 0.8× 218 0.9× 149 0.9× 108 1.5× 14 904
Su-Su Zheng China 14 304 0.8× 253 0.8× 284 1.2× 180 1.1× 77 1.1× 30 746
Karthik Sekar Singapore 13 497 1.2× 305 0.9× 115 0.5× 204 1.3× 67 1.0× 17 720
Vanna Maria Valori Italy 16 601 1.5× 316 1.0× 148 0.6× 92 0.6× 33 0.5× 37 817

Countries citing papers authored by Huawei Zou

Since Specialization
Citations

This map shows the geographic impact of Huawei Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huawei Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huawei Zou more than expected).

Fields of papers citing papers by Huawei Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huawei Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huawei Zou. The network helps show where Huawei Zou may publish in the future.

Co-authorship network of co-authors of Huawei Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Huawei Zou. A scholar is included among the top collaborators of Huawei Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huawei Zou. Huawei Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Huawei, et al.. (2024). A radiomics model to predict γδ T‐cell abundance and overall survival in head and neck squamous cell carcinoma. The FASEB Journal. 38(5). e23529–e23529. 4 indexed citations
2.
Li, Lin, Yuexian Li, & Huawei Zou. (2021). A novel role for apatinib in enhancing radiosensitivity in non-small cell lung cancer cells by suppressing the AKT and ERK pathways. PeerJ. 9. e12356–e12356. 3 indexed citations
3.
Li, Yuexian, et al.. (2020). Transcription levels and prognostic significance of the NFI family members in human cancers. PeerJ. 8. e8816–e8816. 17 indexed citations
4.
Zhao, Xihe, Chenxi Li, Lei Liu, Huawei Zou, & Kai Li. (2020). <p>Identification of Aberrantly Expressed Genes in Murine Glioblastoma During Radiotherapy via Bioinformatic Data Mining</p>. OncoTargets and Therapy. Volume 13. 3839–3851. 4 indexed citations
5.
Sun, Cheng, et al.. (2019). A novel role for NFIA in restoring radiosensitivity in radioresistant NSCLC cells by downregulating the AKT and ERK pathways. Biochemical and Biophysical Research Communications. 515(4). 558–564. 8 indexed citations
6.
Zhang, Heying, Juan Zeng, Yongqiang Tan, et al.. (2018). Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers. OncoTargets and Therapy. Volume 11. 5811–5819. 1 indexed citations
7.
Zeng, Juan, et al.. (2018). Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells. BMC Cancer. 18(1). 611–611. 30 indexed citations
8.
9.
Yan, Shunchao, et al.. (2015). The impact of IGF-1R expression on the outcomes of patients with breast cancer: a&nbsp;meta-analysis. OncoTargets and Therapy. 8. 279–279. 19 indexed citations
10.
11.
Yan, Shunchao, Xin Jiao, Huawei Zou, & Kai Li. (2015). Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases. Diagnostic Pathology. 10(1). 62–62. 65 indexed citations
12.
13.
Yan, Shunchao, Xiujuan Qu, Ling Xu, et al.. (2014). Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Anti-Cancer Drugs. 25(6). 683–689. 33 indexed citations
14.
Li, Kai, et al.. (2013). Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population. Tumor Biology. 35(3). 2343–2350. 10 indexed citations
15.
Li, Kai, et al.. (2013). DNA repair pathway genes and lung cancer susceptibility: A meta-analysis. Gene. 538(2). 361–365. 23 indexed citations
16.
Ma, Jie‐Tao, Cheng‐Bo Han, Wei Jing, et al.. (2012). Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells. Oncology Letters. 4(3). 529–533. 8 indexed citations
17.
18.
19.
Zheng, Wei Xing, et al.. (2010). Identification of MicroRNA Target Genes in Vivo. Molecular Biotechnology. 47(3). 200–204. 2 indexed citations
20.
Zou, Huawei. (2007). Radiosensitivity enhanced by recombinant adenovirus p53 in lung adenocarcinoma. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang Jin Breakdown of academic impact, for papers by Tomohiro Sakuma Breakdown of academic impact, for papers by Maïa Chanrion Breakdown of academic impact, for papers by Jamie R. Kutasovic Breakdown of academic impact, for papers by Linquan Wu Breakdown of academic impact, for papers by Jinjia Chang Breakdown of academic impact, for papers by Jeanie Wu Breakdown of academic impact, for papers by Su-Su Zheng Breakdown of academic impact, for papers by Karthik Sekar Breakdown of academic impact, for papers by Vanna Maria Valori
Rankless by CCL
2026